Slit lamp delivery unit (SL-1800) - This delivery unit is connected to the GYC-1000 - NIDEK CO.,LTD.

Duns Number:690635461

Device Description: This delivery unit is connected to the GYC-1000 main body to comprise the photocoagulation This delivery unit is connected to the GYC-1000 main body to comprise the photocoagulation system and to treat affected areas using the slit lamp, NIDEK SL-1800. A slit lamp delivery unit that includes the SL-1800 comprises a photocoagulation system in connection with the GYC-1000 main body.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

-

Brand Name

Slit lamp delivery unit (SL-1800)

Version/Model Number

17421-0000

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

-

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

-

Product Code Details

Product Code

GEX

Product Code Name

Powered Laser Surgical Instrument

Device Record Status

Public Device Record Key

b927189b-7437-4623-8278-f7ac92018402

Public Version Date

March 29, 2018

Public Version Number

2

DI Record Publish Date

June 24, 2016

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"NIDEK CO.,LTD." Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 39
2 A medical device with a moderate to high risk that requires special controls. 73
3 A medical device with high risk that requires premarket approval 5